NTRR: Federal Court Ruling Achieves Milestone in North America’s Second-Largest Medical Cannabis Market
Feb 25, 2016
OTC Disclosure News Service
In a move that could spur huge opportunities for Neutra
Corp. (OTCQB:NTRR) and others in the North American cannabis
industry, Canada’s federal court significantly increased patients’
access to medicinal cannabis on Wednesday.
A federal court judge ruled that medical cannabis patients have the
right to grow their own plants, reversing a ban instituted by Canada’s
previous government. The ruling was the result of a group of British
Columbia residents taking the nation to court in 2013, arguing that the
law requiring cannabis patients to buy their medication from licensed
producers instead of growing their own violated their Constitutional
NTRR already has numerous relationships within the Canadian cannabis
industry. Alongside its joint venture partner, Surface
to Air Solutions (S2O2), NTRR is working to offer cannabis growers
and other businesses a suite of horticultural technologies designed to
reduce or eliminate reliance upon pesticides to produce healthy crops.
The joint venture’s suite of products includes a plant stimulant, an
antimicrobial hard-surface treatment and air scrubbers. Used together,
the suite of products allows healthy plants to thrive without the use of
pesticides and fungicides, which can be harmful if ingested. Some
products are already in use by growers in the United States and Canada.
The ruling comes on the heels of new Prime Minister Justin Trudeau’s
pledge to legalize adult-use cannabis across Canada, as well. Economists
estimate that the country’s cannabis market could surpass USD $7 billion
annually. To further capitalize on the projected growth of the Canadian
cannabis industry, the company formed another joint venture last month
with Vancouver-based Oceanview Health Services Ltd. to help research
cutting-edge topical creams, oils, salves, lotions and other products
that have been infused with medicinal cannabis. Oceanview is currently
preparing to debut a new brand of cannabis-infused topical products,
BeKind Topicals, in markets where cannabis is legal and regulated.
About Neutra Corp.
As the global cannabis market grows exponentially, it is constantly in
need of better technologies and products to be more efficient in how
they grow, what they grow, and how they consume cannabis and its related
products. From lighting to dosage devices, from pesticide replacements
to plant enhancers, NTRR is constantly combing the industry for the
latest and greatest to test, prove and bring to market.
By providing a variety of new technologies designed to ensure safer,
more reliable access to cannabis in approved markets, Neutra Corp. plans
to compete alongside GW Pharmaceuticals (NASDAQ: GWPH), Cara
Therapeutics Inc. (NASDAQ: CARA) and 22nd Century Group, Inc. (NASDAQ:
XXII). For investing information and performance data, please visit www.neutrainc.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995: This news release contains forward-looking information
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, including statements that include the words “believes,”
“expects,” “anticipate” or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or achievements
of the Company to differ materially from those expressed or implied by
such forward-looking statements. In addition, description of anyone’s
past success, either financial or strategic, is no guarantee of success.
This news release speaks as of the date first set forth above and the
Company assumes no responsibility to update the information included
herein for events occurring after the date hereof.
Copyright © 2016 Businesswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.